Who has invested in Belharra Therapeutics?

Versant Ventures are named among the investors backing Belharra Therapeutics.

Belharra Therapeutics Funding: $130M Raised, Series A (2023)

Belharra Therapeutics funding overview

Belharra Therapeutics is based in San Diego. Belharra Therapeutics has raised $130M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Series A announced in January 2023. The round record for Belharra Therapeutics runs through 2023; nothing later has been disclosed. Investors on record include Versant Ventures.

Belharra Therapeutics at a glance

Total raised: $130M
Latest round: Series A
Latest round date: January 2023
Headquarters: San Diego
Notable investors: Versant Ventures

Frequently asked about Belharra Therapeutics funding

How much has Belharra Therapeutics raised?: Belharra Therapeutics has raised $130M in total disclosed funding across the rounds on record.
Who has invested in Belharra Therapeutics?: Versant Ventures are named among the investors backing Belharra Therapeutics.
What was the latest Belharra Therapeutics funding round?: The most recent disclosed round is a Series A, announced in January 2023.
Where is Belharra Therapeutics based?: Belharra Therapeutics is based in San Diego.
When did Belharra Therapeutics last raise?: The last disclosed Belharra Therapeutics round closed in January 2023 at Series A.

Totals shown for Belharra Therapeutics aggregate every disclosed round on file. To see how that compares, browse the companies in San Diego and the investors behind them below.

Belharra Therapeutics Funding: $130M Raised, Series A (2023)

Belharra Therapeutics funding overview

Belharra Therapeutics at a glance

Frequently asked about Belharra Therapeutics funding

Companies related to Belharra Therapeutics (36)

Browse related funding lists (6)